Journal of Parkinsons Disease

Papers
(The H4-Index of Journal of Parkinsons Disease is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
When Parkinson's disease interferes in a couple's life: A qualitative study90
Acknowledgment to reviewers 202587
Feasibility and potential effectiveness of an exergame program for people with moderate to advanced Parkinson's disease: A pilot randomized controlled trial84
A prospective analysis of falls in Parkinson's disease: Does physical capacity moderate the relationship between walking amount and falls rates?78
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease74
A framework to standardize gait study protocols in Parkinson's disease63
Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort63
Clinical Trial Highlights: Modulators of Mitochondrial Function62
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists61
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?57
Creation of a machine learning-based model for early identification of mild cognitive impairment risk in Parkinson's disease: A PD research center-based population study55
One world, one goal: Advocacy and policy for a unified Parkinson's response55
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease54
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression53
Impact and management of cognition on speech and swallow function in Parkinson's disease46
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention44
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis43
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease42
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease41
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease41
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients38
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?37
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders34
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”34
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”34
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease34
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative33
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease32
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review31
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort31
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease30
The fixel GI Parkinson's research and integrated support model (PRISM)30
A possible pathway to freezing of gait in Parkinson's disease30
0.10409688949585